129 related articles for article (PubMed ID: 38643755)
21. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma.
Mao Y; Xu R
Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486
[TBL] [Abstract][Full Text] [Related]
22. PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells.
He S; Ma X; Zheng N; Wang G; Wang M; Xia W; Yu D
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355367
[TBL] [Abstract][Full Text] [Related]
23. Transcription Factor ETV4 Activates AURKA to Promote PD-L1 Expression and Mediate Immune Escape in Lung Adenocarcinoma.
Yang P; He S; Ye L; Weng H
Int Arch Allergy Immunol; 2024 May; ():1-11. PubMed ID: 38781935
[TBL] [Abstract][Full Text] [Related]
24. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
[TBL] [Abstract][Full Text] [Related]
25. [S100A10 promotes proliferation and invasion of lung adenocarcinoma cells by activating the Akt-mTOR signaling pathway].
Wang H; Sun Z; Zhao W; Geng B
Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):733-740. PubMed ID: 37313814
[TBL] [Abstract][Full Text] [Related]
26. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.
Gao W; Zhang Y; Luo H; Niu M; Zheng X; Hu W; Cui J; Xue X; Bo Y; Dai F; Lu Y; Yang D; Guo Y; Guo H; Li H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Ma T; Jin L; Xu W; Wu Y
Cell Death Dis; 2020 Oct; 11(10):919. PubMed ID: 33106477
[TBL] [Abstract][Full Text] [Related]
27. TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway.
Xiong Y; Feng Y; Zhao J; Lei J; Qiao T; Zhou Y; Lu Q; Jiang T; Jia L; Han Y
Cell Death Dis; 2021 Apr; 12(4):352. PubMed ID: 33824285
[TBL] [Abstract][Full Text] [Related]
28. LncRNA AP000695.2 promotes glycolysis of lung adenocarcinoma via the miR-335-3p/TEAD1 axis.
Xu S; Cheng Z; Du B; Diao Y; Li Y; Li X
Acta Biochim Biophys Sin (Shanghai); 2023 Oct; 55(10):1592-1605. PubMed ID: 37723874
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
30. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis.
Hu DD; Chen HL; Lou LM; Zhang H; Yang GL
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068236
[TBL] [Abstract][Full Text] [Related]
31. Circular RNA P4HB promotes glycolysis and tumor progression by binding with PKM2 in lung adenocarcinoma.
Li H; Guo H; Huang Q; Wang S; Li X; Qiu M
Respir Res; 2023 Oct; 24(1):252. PubMed ID: 37880717
[TBL] [Abstract][Full Text] [Related]
32. CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis.
Yu SK; Yu T; Wang YM; Sun A; Liu J; Lu KH
J Transl Med; 2024 May; 22(1):460. PubMed ID: 38750462
[TBL] [Abstract][Full Text] [Related]
33. Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma.
Li R; Liu J; Fang Z; Liang Z; Chen X
Front Pharmacol; 2020; 11():572627. PubMed ID: 33192515
[No Abstract] [Full Text] [Related]
34. GIMAP7 inhibits epithelial-mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway.
Cui L; Shen Y; Duan S; Ding Q; Wang Y; Yang W; Chen Y
Thorac Cancer; 2024 Feb; 15(4):286-298. PubMed ID: 38151913
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3.
Wang T; Zhu X; Wang K; Li J; Hu X; Lin P; Zhang J
Pulm Pharmacol Ther; 2023 Jun; 80():102217. PubMed ID: 37121465
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor E2F8 activates PDK1-mediated DNA damage repair to enhance cisplatin resistance in lung adenocarcinoma.
Li H; Sun J; Hu H; Wang Y
Pharmacology; 2024 May; ():. PubMed ID: 38810606
[TBL] [Abstract][Full Text] [Related]
37. Transcription Factor MITF Inhibits the Transcription of CPT1B to Regulate Fatty Acid β-Oxidation and Thus Affects Stemness in Lung Adenocarcinoma Cells.
Tang W; Tang H; Xu S; Yu H; Chen Z
Pharmacology; 2024; 109(1):52-64. PubMed ID: 38016436
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA MAFG-AS1 knockdown blocks malignant progression in breast cancer cells by inactivating JAK2/STAT3 signaling pathway via MAFG-AS1/miR-3196/TFAP2A axis.
Ding M; Fu Y; Guo F; Chen H; Fu X; Tan W; Zhang H
Int J Clin Exp Pathol; 2020; 13(10):2455-2473. PubMed ID: 33165437
[TBL] [Abstract][Full Text] [Related]
39. USF1-CHCHD4 axis promotes lung adenocarcinoma progression partially via activating the MYC pathway.
Zhou Y; Zhao Y; Ma W; Zhang L; Jiang Y; Dong W
Discov Oncol; 2022 Dec; 13(1):136. PubMed ID: 36482116
[TBL] [Abstract][Full Text] [Related]
40. RTKN2 Inhibits the Growth, Migration, Invasion and Glycolysis of Lung Adenocarcinoma Cells by Inactivating the NF-κB Signalling Pathway.
Wang N; Wang J
Biochem Genet; 2023 Oct; 61(5):2135-2148. PubMed ID: 36952123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
